Regencell Bioscience Holdings Limited

NASDAQ (USD): Regencell Bioscience Holdings Limited (RGC)

Last Price

430.07

Today's Change

+28.07 (6.98%)

Day's Change

420.01 - 474.18

Trading Volume

24,634

Overview

Market Cap

5 Billion

Shares Outstanding

13 Million

Avg Volume

706,729

Avg Price (50 Days)

75.57

Avg Price (200 Days)

23.31

PE Ratio

-1155.88

EPS

-0.34

Earnings Announcement

24-Jan-2025

Previous Close

402.00

Open

430.00

Day's Range

382.85 - 474.1873

Year Range

3.03 - 550.0

Trading Volume

34,905

Price Change Highlight

1 Day Change

-2.24%

5 Day Change

-12.45%

1 Month Change

1255.17%

3 Month Change

10521.62%

6 Month Change

5854.55%

Ytd Change

8053.53%

1 Year Change

7666.80%

3 Year Change

1484.68%

5 Year Change

3642.86%

10 Year Change

3642.86%

Max Change

3642.86%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment